Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-25 4:29 pm Purchase |
2022-05-15 | 13G | Celcuity Inc. CELC |
RA Capital Management, L.P. | 1,486,471 9.900% |
1,486,471 (New Position) |
Filing History |
| 2022-05-20 4:30 pm Purchase |
2022-05-10 | 13D | PepGen Inc. PEPG |
RA Capital Management, L.P. | 8,131,952 36.300% |
8,131,952 (New Position) |
Filing History |
| 2022-05-16 4:33 pm Sale |
2022-05-16 | 13G | Zogenix, Inc. ZGNX |
RA Capital Management, L.P. | 0 0.000% |
-3,333,700 (Position Closed) |
Filing History |
| 2022-05-16 4:32 pm Sale |
2022-05-16 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
RA Capital Management, L.P. | 0 0.000% |
-3,115,008 (Position Closed) |
Filing History |
| 2022-05-16 4:31 pm Sale |
2022-05-16 | 13G | Bolt Biotherapeutics, Inc. BOLT |
RA Capital Management, L.P. | 0 0.000% |
-2,378,325 (Position Closed) |
Filing History |
| 2022-05-16 4:30 pm Sale |
2022-05-16 | 13G | Olema Pharmaceuticals, Inc. OLMA |
RA Capital Management, L.P. | 0 0.000% |
-2,150,404 (Position Closed) |
Filing History |
| 2022-05-02 4:30 pm Purchase |
2022-04-28 | 13D | Nkarta, Inc. NKTX |
RA Capital Management, L.P. | 7,832,340 16.200% |
2,227,211 (+39.74%) |
Filing History |
| 2022-04-28 4:58 pm Purchase |
2022-04-18 | 13G | NanoString Technologies, Inc. NSTGQ |
RA Capital Management, L.P. | 3,517,694 7.700% |
3,517,694 (New Position) |
Filing History |
| 2022-04-25 4:30 pm Purchase |
2022-04-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
RA Capital Management, L.P. | 4,398,453 7.100% |
4,398,453 (New Position) |
Filing History |
| 2022-04-21 4:30 pm Purchase |
2022-04-11 | 13G | Veru Inc. VERU |
RA Capital Management, L.P. | 7,900,000 9.870% |
7,900,000 (New Position) |
Filing History |
| 2022-04-08 4:31 pm Purchase |
2022-03-29 | 13G | AN2 Therapeutics, Inc. ANTX |
RA Capital Management, L.P. | 3,666,663 19.600% |
3,666,663 (New Position) |
Filing History |
| 2022-04-01 4:30 pm Sale |
2022-03-30 | 13D | Kala Pharmaceuticals, Inc. KALA |
RA Capital Management, L.P. | 436,585 15.030% |
-1,877 (-0.43%) |
Filing History |
| 2022-03-24 4:30 pm Purchase |
2022-03-14 | 13G | Standard BioTools Inc. LAB |
RA Capital Management, L.P. | 4,651,177 6.000% |
4,651,177 (New Position) |
Filing History |
| 2022-03-14 5:04 pm Purchase |
2022-03-10 | 13D | Cytek Biosciences, Inc. CTKB |
RA Capital Management, L.P. | 13,139,327 9.800% |
2,057,164 (+18.56%) |
Filing History |
| 2022-02-28 5:29 pm Purchase |
2022-02-28 | 13D | Cytek Biosciences, Inc. CTKB |
RA Capital Management, L.P. | 11,082,163 8.300% |
1,475,135 (+15.35%) |
Filing History |
| 2022-02-24 4:30 pm Purchase |
2022-02-14 | 13G | Vera Therapeutics, Inc. VERA |
RA Capital Management, L.P. | 2,000,000 7.500% |
2,000,000 (New Position) |
Filing History |
| 2022-02-18 4:36 pm Sale |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 2,691,770 9.840% |
-4,000,000 (-59.77%) |
Filing History |
| 2022-02-14 4:11 pm Unchanged |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
RA Capital Management, L.P. | 2,850,000 5.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 5,614,428 9.200% |
1,056,561 (+23.18%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 6,691,770 9.840% |
3,172,772 (+90.16%) |
Filing History |